Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pittcon Now Accepting Grant Proposals for 2014

Published: Monday, July 15, 2013
Last Updated: Monday, July 15, 2013
Bookmark and Share
The Pittsburgh Conference and its sponsoring societies are now accepting proposals for the 2014 Pittsburgh Conference Memorial National College Grants (PCMNCG) Award Program.

The Pittsburgh Conference and its sponsoring societies, the Spectroscopy Society of Pittsburgh (SSP) and the Society for Analytical Chemists of Pittsburgh (SACP), are now accepting proposals for the 2014 Pittsburgh Conference Memorial National College Grants (PCMNCG) Award Program. Qualifying organizations are invited to consider applying for one of this year's awards. The deadline for receipt of completed applications and proposals is October 1, 2013.

Click here to get information about the award, the application form, a description of the eligibility criteria, and a list of previous award recipients.

Awards will be announced during the month of January 2014. Schools chosen will join the list of more than 300 institutions honored since the inception of this program in 1974. In 1974, two grants of $1,000 each were given. This year, the maximum funding available for each grant is $10,000, and there will be at least 10 of these awards. Each proposal will be reviewed by an evaluation committee comprised of members of the SSP and the SACP. Last year, there were 49 proposals from small colleges and universities who met the requirements.

The Pittsburgh Conference Memorial National College Grants Program, originally established in memory of R. K. Scott, 1955 president of the Pittsburgh Conference, serves as a memorial to deceased members of the Pittsburgh Conference Committee by promoting excellence in science education. Through the program, small colleges can enhance their science curricula through grants to purchase equipment and course materials.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!